Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Advanced Thyroid Cancer
NCT02084732Phase 2Completed
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Oct 2013
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in thyroid cancer, sponsored by Instituto Nacional de Cancerología. Started Oct 2013; status: completed.
02
Drugs
sorafenib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT02084732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084732.